Japan's EditForce & Mitsubishi ink gene therapy deal for ¥20 B
Japan | News | 0 Comment | 05 Jul, 2022
Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...Read more
Fujifilm invests $1.6 B to expand global offering of cell culture manufacturing services
Japan | News | 0 Comment | 04 Jul, 2022
Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...Read more
Novel AI-driven automation platform enables optimization of laboratory protocols
Japan | News | 0 Comment | 01 Jul, 2022
In collaboration with a Japanese firm SBX Corporation, a Swiss-based firm Philip Morris International has deve...Read more
Catalent expands primary packaging capabilities in Japan
Japan | News | 0 Comment | 01 Jul, 2022
Catalent has announced the expansion of its primary packaging capabilities at its clinical supply facility in Shiga...Read more
Labcorp plans expansion in Japan through BML collaboration
Japan | News | 0 Comment | 29 Jun, 2022
Labcorp, a leading global life sciences company, has announced that it is enhancing its central laboratory presence and ...Read more
Sanofi partners with Health2Sync for diabetes management in Japan
Japan | News | 0 Comment | 28 Jun, 2022
Sanofi Japan and Taiwan-based startup Health2Sync have entered into a partnering agreement to support healthcare profess...Read more
Japan discovers new type of bone repairing material
Japan | News | 0 Comment | 27 Jun, 2022
Ceramics and metals have been used for a while as structural materials to repair bones and joints. In the past, scientis...Read more
Japan-based Fujirebio acquires ADx Neurosciences for €40 M
Japan | News | 0 Comment | 24 Jun, 2022
Japan's H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and Belgium-based ADx NeuroS...Read more
Fujitsu, Salesforce start collaboration on healthcare solutions for Japan market
Japan | News | 0 Comment | 23 Jun, 2022
Fujitsu and Salesforce Japan have announced the start of a collaboration to create new digital solutions for the healthc...Read more
Japan's Nippon Express launches new service for vaccine transport
Japan | News | 0 Comment | 21 Jun, 2022
Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., (NX Group) has become the first Japanese log...Read more
Saint-Gobain Life Sciences expands manufacturing capacity in Japan
Japan | News | 0 Comment | 17 Jun, 2022
French firm Saint-Gobain Life Sciences has announced the expansion of its manufacturing facility in Suwa, Japan to ...Read more
Takeda's dengue vaccine proves protection through 4.5 yrs of clinical trials
Japan | News | 0 Comment | 15 Jun, 2022
Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...Read more
Shionogi expands access to Cefiderocol in 135 countries to treat bacterial infections
Japan | News | 0 Comment | 15 Jun, 2022
Japan-based Shionogi & Co. and the Global Antibiotic Research and Development Partnership (GARDP) have announced the...Read more
Nippon Express launches ultra-low temp-controlled pharma logistics service
Japan | News | 0 Comment | 13 Jun, 2022
Japan's Nippon Express, a group company of Nippon Express Holdings, Inc., launched a logistics service capable of handli...Read more
Major milestone for secondary fracture prevention announced in Japan
Japan | News | 0 Comment | 10 Jun, 2022
An estimated 13 million people are living with osteoporosis in Japan. The bone disorder results in painful and disabling...Read more
Japanese startup LUCA Science raises $30.3 M in Series B funding
Japan | News | 0 Comment | 06 Jun, 2022
Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...Read more
Japan's Daiichi Sankyo to commercialise mRNA vaccine against COVID-19 in 2022
Japan | News | 0 Comment | 03 Jun, 2022
Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...Read more
Japan approves ViiV Healthcare's combination drug for HIV
Japan | News | 0 Comment | 02 Jun, 2022
ViiV Healthcare, the global specialist HIV company majority-owned by GSK with Pfizer and Shionogi as shareholders, has o...Read more